Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Pulmonary and Cardiovascular Safety of Exubera in Diabetes Mellitus
2006-001996-39Phase 4Completed
- Sponsor
- Pfizer
- Start
- May 2006
- Countries
- 1
01
Overview
Phase 4, open-label trial of Technosphere insulin in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM), sponsored by Pfizer. Primary endpoint: Long-term change in FEV1 (spirometry). Started May 2006; status: completed.
02
Drugs
Technosphere insulin
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-001996-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001996-39.